Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its ...

(RTTNews) - Kyverna Therapeutics, Inc. (KYTX) a California-based biopharmaceutical company, Tuesday announced the appointment of Naji Gehchan as Chief Medical and Development Officer. Gehchan will ...

EMERYVILLE, Calif. - Kyverna Therapeutics Inc. (NASDAQ: KYTX), a clinical-stage biopharmaceutical company with a market capitalization of $144 million, today announced the appointment of Dr. Naji ...

Dr. Gehchan brings decades of successful late-stage clinical development and commercial experience to role, further enhancing Kyverna's senior leadership team to execute Company's next wave of ...

In connection with the appointment of Dr. Gehchan as Kyverna's Chief Medical and Development Officer, on January 22, 2025, Kyverna will grant Dr. Gehchan an option to purchase 425,000 shares of ...

EMERYVILLE, Calif. - Kyverna Therapeutics Inc. (NASDAQ: KYTX), a clinical-stage biopharmaceutical company with a market capitalization of $144 million, today announced the appointment of Dr. Naji ...

Kyverna Therapeutics logo (PRNewsfoto/Kyverna Therapeutics) "We are thrilled to welcome Naji, a seasoned clinical development leader skilled in immunology, to our team as we prepare for our next phase ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to Kyverna's initial public ...